Betterlife Pharma Inc (BETRF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 01/31
| 01-2021 | 01-2020 | 01-2019 | 01-2018 | 01-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,201 | -14,784 | -7,015 | -121 | -6,278 |
| Depreciation Amortization | 257 | 1,063 | 1,083 | 131 | 70 |
| Accounts receivable | -262 | -70 | N/A | N/A | N/A |
| Other Working Capital | -1,156 | 228 | 558 | 508 | 599 |
| Other Operating Activity | 23,001 | 7,616 | 1,557 | -913 | 5,250 |
| Operating Cash Flow | $-5,362 | $-5,948 | $-3,818 | $-396 | $-359 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8 | -410 | N/A | N/A | N/A |
| Net Acquisitions | 19 | -327 | 2 | N/A | N/A |
| Purchase Sale Intangibles | -65 | N/A | -655 | N/A | N/A |
| Other Investing Activity | -65 | -125 | -654 | 0 | 0 |
| Investing Cash Flow | $-54 | $-861 | $-652 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 449 | -2,453 | 3,882 | 37 | 380 |
| Debt Repayment | N/A | -207 | -591 | N/A | N/A |
| Common Stock Issued | 2,985 | 12,309 | N/A | 324 | N/A |
| Other Financing Activity | -374 | -422 | 1,178 | 0 | 0 |
| Financing Cash Flow | $3,060 | $9,227 | $4,469 | $361 | $380 |
| Exchange Rate Effect | 15 | 2 | -3 | -13 | 21 |
| Beginning Cash Position | 2,456 | 57 | 61 | 112 | 72 |
| End Cash Position | 116 | 2,477 | 57 | 65 | 112 |
| Net Cash Flow | $-2,340 | $2,420 | $-4 | $-48 | $41 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,362 | -5,948 | -3,818 | -396 | -359 |
| Capital Expenditure | -8 | -410 | N/A | N/A | N/A |
| Free Cash Flow | -5,369 | -6,357 | -3,818 | -396 | -359 |